Ozempic Lawsuit in Michigan (GLP-1 Claims)
Information for Michigan residents researching Ozempic and GLP-1 lawsuits: gastroparesis and bowel-injury allegations, MDL-3094 status, eligibility factors, records, and Michigan filing deadlines.
This guide is for general information only. It does not provide legal advice, does not create an attorney-client relationship, and case status can change.
What Michigan residents should know
Michigan residents with GLP-1 injury claims are generally not limited to Michigan state court. Most filed cases are transferred into the federal multidistrict litigation, MDL-3094, before Judge Karen S. Marston in the Eastern District of Pennsylvania, which held 3,763 pending cases as of June 1, 2026.
Michigan law still matters: the state's filing deadline, damages rules, and procedural law can shape an individual claim even when the case is litigated in the MDL.
Possible eligibility factors
- Documented use of a GLP-1 medication (prescription and pharmacy records from Michigan providers).
- A diagnosis such as gastroparesis, ileus, or bowel obstruction — commonly supported by a gastric emptying study, endoscopy, imaging, or hospitalization records.
- Injury timing consistent with medication use.
- Filing within the deadline that applies to the claim under Michigan law.
How Michigan claims proceed
Most Michigan GLP-1 cases are filed in or transferred to MDL-3094 in the Eastern District of Pennsylvania for coordinated proceedings. The court has scheduled Rule 702 expert-admissibility hearings for September 10–18, 2026 (Case Management Order No. 32); bellwether trial dates have not yet been set. Michigan's general personal injury limitations period is 3 years (Mich. Comp. Laws § 600.5805(2)), but accrual and discovery-rule questions are fact-specific for injuries that develop during ongoing medication use.
Records to gather
- Medical records related to diagnosis, treatment, and symptoms.
- Records showing use of, prescription for, or exposure to the product or substance involved.
- Pharmacy, clinic, employment, military, agricultural, or exposure records where relevant.
- Photos, receipts, dental invoices, pathology reports, or specialist records if applicable.
State-specific exposure and context
Michigan residents may have been prescribed Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, Zepbound, or Trulicity through endocrinologists, primary care practices, weight-management clinics, telehealth services, or hospital systems across the state.
Where cases may be handled
Living in Michigan does not necessarily mean the case will be filed only in Michigan. Claims may be evaluated by national firms, filed in federal court, coordinated through MDL proceedings, or handled through another legal process.
Federal courts in Michigan
- Eastern District of Michigan
- Western District of Michigan
How long do Michigan residents have to file?
Michigan's general personal injury statute of limitations is 3 years (Mich. Comp. Laws § 600.5805(2)). Product liability and toxic exposure claims do not always follow the general rule — accrual timing, tolling, and repose periods can change the real deadline in an individual case.
- General personal injury period: 3 years — Mich. Comp. Laws § 600.5805(2).
- Discovery rule: Michigan applies limited discovery-based accrual rules; latent-injury treatment varies by claim type.
Because the controlling deadline depends on diagnosis date, discovery facts, exposure history, wrongful-death rules, and how the claim is filed, only a licensed attorney can confirm the deadline that applies to a specific situation. This page is general legal information, not legal advice.
Questions to ask a lawyer
- Are you currently reviewing Ozempic / GLP-1 claims?
- What records do you need to evaluate my claim?
- How do Michigan filing deadlines affect my situation?
- Would my claim be handled locally, nationally, or through an MDL?
- Do you work directly on this case or refer it to another firm?
- Are there upfront costs?
Frequently Asked Questions
What is the Ozempic lawsuit in Michigan about?
Lawsuits allege GLP-1 medications such as Ozempic can cause gastroparesis, ileus, and bowel obstruction, and that warnings were inadequate. Michigan residents' cases are generally transferred into federal MDL-3094 for coordinated proceedings. Defendants dispute the allegations.
Can a Michigan resident join the Ozempic MDL?
Possibly. Cases filed by Michigan residents in federal court are routinely transferred into MDL-3094 in the Eastern District of Pennsylvania. Whether an individual claim is filed there depends on case strategy and individual facts.
What is the Ozempic lawsuit statute of limitations in Michigan?
Michigan's general personal injury period is 3 years (Mich. Comp. Laws § 600.5805(2)), and michigan applies limited discovery-based accrual rules; latent-injury treatment varies by claim type. Only a lawyer can confirm the deadline for a specific situation.
Which drugs are included for Michigan claimants?
Filed cases involve Ozempic, Wegovy, Rybelsus, and Saxenda (Novo Nordisk) and Mounjaro, Zepbound, and Trulicity (Eli Lilly). Both diabetes and weight-loss prescriptions appear among filed cases.
What records matter most for a Michigan claim?
Prescription and pharmacy records, gastroenterology records, gastric emptying study results, hospitalization records, and imaging or endoscopy reports are commonly requested first.
Has there been an Ozempic settlement?
No. As of June 2026 no settlement program exists in the GLP-1 litigation. The Rule 702 hearings set for September 10-18, 2026 and the rulings that follow are the next events expected to shape settlement posture. Bellwether trial dates have not been set, and no outcome is guaranteed.
Is Ozempic recalled?
No. GLP-1 medications remain FDA-approved and on the market. The litigation concerns warnings and alleged injuries, not availability. Medication decisions belong with a licensed healthcare professional.
Does this page provide legal advice?
No. This page is general legal information for research purposes only and does not create an attorney-client relationship.
Other Lawsuit Guides in Michigan
AFFF Firefighting Foam Lawsuit in Michigan
Active / Investigating
Camp Lejeune Claims for Michigan Residents
Active — Filing Deadline Passed
Depo-Provera Lawsuit in Michigan
Active / Investigating
Paraquat Parkinson's Lawsuit in Michigan
Active / Investigating
Roundup Cancer Lawsuit in Michigan
Active / Investigating
Suboxone Tooth Decay Lawsuit in Michigan
Active / Investigating
Sources and Update Log
- Last reviewed
- June 11, 2026
- Last updated
- June 11, 2026
Sources reviewed may include court filings, MDL notices, public agency materials, manufacturer disclosures, and law firm case-status updates where applicable.
Recent updates focus on lawsuit status, state-specific context, eligibility factors, records, deadlines, and editorial disclosures.